Speaker Profile
PMWC LUMINARY AWARD
Transformed the precision oncology field through the development of the advanced non-invasive liquid biopsy
Ph.D., Chairman and Co-CEO, Guardant Health
Biography
Helmy Eltoukhy is a scientist and biotech entrepreneur with contributions to nextgeneration DNA sequencing and noninvasive liquid biopsy technologies. Eltoukhy is the cofounder and Chairman and coCEO of Guardant Health (NASDAQ:GH). Under his leadership, Guardant Health launched the first comprehensive liquid biopsy for advancedstage cancer patients and the first bloodonly liquid biopsy for recurrence monitoring for cancer survivors. The company also completed a 20,000 patient clinical study to validate a blood test for the early detection of colorectal cancer. Previously, he cofounded Avantome to commercialize semiconductorbased sequencing, which was later acquired by Illumina. He was named to Time Magazines inaugural 50 Most Influential People in Healthcare, Fortunes 40 under 40, and in the 2021 list of the Top 50 Healthcare CEOs. He received his PhD, MS and BS degrees from Stanford University. He has coauthored highimpact publications spanning the sequencing and cancer fields and is a coinventor on over 50 issued US patents.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Luminary Honorees: Helmy Eltoukhy & AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Bruna Pellini, Moffitt Cancer Center
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio - Liquid Biopsy in Early Cancer Detection (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, Cancer Screening Research Network (CSRN) - Keynote: Pioneering Liquid Nucleic acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - PMWC Showcase
- Sandrine Miller-Montgomery, Micronoma
